VALIANT LABORATORIES LIMITED
₹ 133 - ₹ 140
27-Sep-2023 - 03-Oct-2023
₹ 14700.00

/ 105 Shares

VALIANT LABORATORIES LIMITED

27-Sep-2023 - 03-Oct-2023

₹ 133 - ₹ 140

Price Band

₹ 14700.00

Minimum Investment

105

Bid Lot

10,890,000

Shares

IPO Details

Fresh Issue of 10,890,000 Equity shares

Category % Shares/Amount
QIB 50% 5,445,000 Shares Rs.76.23 Cr
HNI 1 5% 544,500 Shares Rs. 7.62 Cr @ 370 Form 1x
HNI 2 10% 1,089,000 Shares Rs. 15.25 Cr @ 741 Form 1x
Retail 35% 3,811,500 Shares Rs. 53.36 Cr @ 36300 Form 1x

BRLM Unistone Capital

Application Require for 1 Time

Retail (Upto 2 Lakh) HNI (2 Lakh to 10 Lakh) HNI (Above 10 Lakh)
36300 Form 1x 370 Form 1x 741 Form 1x

IPO Lot Size

Category Lots Shares Amount
Retail (Upto 2 Lakh) 1 105 ₹ 14,700
Retail (Upto 2 Lakh) 13 1365 ₹ 191,100
S-HNI (2 Lakh to 10 Lakh) 14 1470 ₹ 205,800
S-HNI (2 Lakh to 10 Lakh) 68 7140 ₹ 999,600
B-HNI (Above 10 Lakh) 69 7245 ₹ 1,014,300

IPO Timeline

  • Open Date

    27-Sep-2023

  • Close Date

    03-Oct-2023

  • Basis of Allotment Date

    05-Oct-2023

  • Initiation of Refunds

    06-Oct-2023

  • Credit Shares to Demat A/c

    06-Oct-2023

  • IPO Listing Date

    09-Oct-2023

Subscription as on
03-Oct-2023 11:31

Category Book Size Subscription No. of Times
QIB 2,178,000 ₹ 30.49 Cr. 2,300,550 ₹ 32.21 Cr. 1.06x
HNI (<10 LAKH) 544,500 ₹ 7.62 Cr. 6,780,375 ₹ 94.93 Cr. 12.45x
HNI2 (>10 LAKH) 1,089,000 ₹ 15.25 Cr. 13,442,940 ₹ 188.20 Cr. 12.34x
RETAIL 3,811,500 ₹ 53.36 Cr. 24,006,780 ₹ 336.09 Cr. 6.30x
Total 7,623,000 46,530,645 6.10x
Category Book Size Subscription No. of Times
QIB 2,178,000 ₹ 30.49 Cr. 2,300,550 ₹ 32.21 Cr. 1.06x
HNI (<10 LAKH) 544,500 ₹ 7.62 Cr. 6,780,375 ₹ 94.93 Cr. 12.45x
HNI2 (>10 LAKH) 1,089,000 ₹ 15.25 Cr. 13,442,940 ₹ 188.20 Cr. 12.34x
RETAIL 3,811,500 ₹ 53.36 Cr. 24,006,780 ₹ 336.09 Cr. 6.30x
Total 7,623,000 46,530,645 6.10x

*Excluding Anchor

Total No. of Application Approx : ~223826 (6.17 Appwise)

Disclaimer: The above-mentioned information / data are sourced from the websites of National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) and are subject to change on real time basis. For updated information / data you can visit their respective website. The information / data provided herein above are for information purpose only and provided "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. We do not guarantee or warrant the accuracy, adequacy or completeness of the information received through the said websites. “We” hold not responsibility of any kind as regard to any discrepancies, errors, omissions, losses or damages. “We” including its affiliates and any of its officers, directors, personnel and employees, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of information / data received through the said websites. The recipient alone shall be fully responsible / are liable for any decision taken on the basis of such information / data. All recipients should before acting upon the said information make their own investigation, seek appropriate professional advice.

About Company

  1. Valiant Laboratories Limited (“Valiant”) was incorporated on October 17, 1980. Valiant is an Active Pharmaceutical Ingredient (“API”) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. Bulk drugs/API serve as raw materials for manufacturing finished dosage forms or formulations. 
  2. Valiant manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of their customers.
  3. Valiant, through their wholly owned subsidiary, Valiant Advanced Sciences Pvt Ltd intend to establish a greenfield project at Bharuch, Gujarat, which shall be spread over an aggregate parcel of land admeasuring about 57,766 sq. mtrs. (“Proposed Facility”) which shall venture into manufacture of speciality chemicals such as ketene and diketene derivative products.
  4. Valiant has experienced promoter and strong management team. One of the Promoter, i.e. Shantilal Shivji Vora has over have 45 years of experience in the field of chemical and pharma.  
  5. Valiant has strong Focus on Sustainability in Operations. The revenue from operations grew at a CAGR of 23.90% between Fiscal 2017 and Fiscal 2023. The restated profit after tax, grew at a CAGR of 26.81% between Fiscal 2017 and Fiscal 2023. 
  6. Company’s manufacturing Facility is strategically located at a distance of about 150 Kms. from JNPT (Nhava Sheva) Port.  
  7. They have Quality-Focused Compliant Manufacturing and R&D Infrastructure. They are able to achieve high level of purity i.e. 99.5% for their final product through continuous focus on quality and R&D. 
  8. Valiant has reduced dependency on import of raw materials for para–amino phenol from 78.06% for the fiscal 2020 to 11.92% for fiscal 2023.
Read More

Strengths

Competitive Strength 

  • Experienced promoters and strong management team;
  • Strong financial performance;
  • Reducing dependence on import of raw materials;
  • Strategically located Manufacturing Facility. 

Business Strategies 

  • Diversification into new chemistries and industry;
  • Increase in market share;
  • Improve operational efficiencies through backward integration of Proposed Facility;
  • Increase the penetration into international markets including regulated markets.

Company Promoters

Velji Karamshi Gogri is the Independent and Non-Executive Director of the company. Santosh Shantilal Vora is the Managing Director of the company. Shantilal Shivji Vora is the Non-Executive Director of the company. Paresh Shashikant Shah is the Executive Director and Chief Financial Officer of the company. Sonal Amit Vira is the Independent Director of the Company. Sandeep Gupta is the Non-Executive Director of the company. Saloni Mehta is the Company Secretary & Compliance Officer of the

Company Financials

Valiant Laboratories IPO Financial Information (Restated Standalone)
Period Ended 31 Mar 2021 31 Mar 2022 31 Mar 2023
Assets 106.31 181.81 212.76
Revenue 183.78 293.47 338.77
Profit After Tax 30.59 27.50 29.00
Net Worth 88.58 71.46 100.49
Reserves and Surplus      
Total Borrowing 0.35 60.68 59.40

Amount in ? Crore

Objects of the Issue

  1. Investment in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for specialty chemicals at Saykha Industrial Area, Bharuch, Bharuch, Gujarat (Proposed Facility).
  2. Investment in VASPL for funding its working capital requirements.
  3. General corporate purposes.

How to Apply

Apply for IPO in few simple steps.

  • Step 01 :

    Once you create your account, Login to InvestoYard.

  • Step 02 :

    Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.

  • Step 03 :

    Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).

  • Step 04 :

    Enter your UPI ID and you will receive mandate on your UPI App.

  • Step 05 :

    Once you accept the mandate, Application is submitted successful.

  • Applying for an IPO is easier than ever with InvestoYard, in just a few clicks your application is processed. You can bid for any IPO through InvestoYard, the bidding process is simple and hassle free. Every company has a lot size decided & you can buy in multiples of the decided lot.
  • If lot size is 15, then you have to bid for multiples of 15 share like 30,45,60 and so on.
  • The maximum subscription amount for retail investors is 2 lakh.
  • Any bid can be at a desired price or cut off price given by the company.

  • Enter the number of shares you wish to buy, as per the lot size.
  • You can apply at the cut off price set by the company or bid for a desired amount within the price band.
  • Maximum three bids will be accepted.
  • You then need to enter the UPI ID on InvestoYard’s IPO application form.

  • You will immediately get a fund blocked request on your UPI for the submitted IPO application.
  • The funds will be blocked in your bank account until allotment when it is debited.
  • The limit for IPO application is Rs 2 lakh per transaction on UPI.
  • On allotment of the shares, the money will be automatically debited.
  • If the share aren’t allotted the blocked funds will reflect back into your account.

Frequently Asked Questions

Check Allotment